SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-097031
Filing Date
2024-08-14
Accepted
2024-08-14 16:15:05
Documents
1
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 14698
  Complete submission text file 0000950170-24-097031.txt   16111
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Issuer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FORBION CAPITAL FUND IV COOPERATIEF GOOMIER 2-35 NAARDEN P7 14111 DC
Business Address
Kersten Dirk (Reporting) CIK: 0001823682 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39509 | Film No.: 241207989